Meeder Asset Management »

Castle Biosciences shares owned by Meeder Asset Management

Quarter-by-quarter ownership of Castle Biosciences (CSTL) shares owned by Meeder Asset Management from 13F filings

Historical chart of Meeder Asset Management investment in Castle Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Castle Biosciences held by Meeder Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Castle Biosciences by Meeder Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $9.5k 387 24.55
2020-09-30 $0 1.3k 0.00

More positions owned by Meeder Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Microsoft Corporation (MSFT)
Mastercard Incorporated Cl A (MA)
Spdr Series Trust State Street Spd (JNK)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Meta Platforms Cl A (META)
General Dynamics Corporation (GD)
Johnson & Johnson (JNJ)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
Amgen (AMGN)
Chevron Corporation (CVX)

View all positions for Meeder Asset Management

Top funds holding Castle Biosciences

BlackRock
Rtw Investments
Principal Financial Group
Portolan Capital Management
Vanguard Capital Management
Dimensional Fund Advisors
Summit Partners Public Asset Management
Vanguard Portfolio Management
Allianz Asset Management
State Street Corporation
Geode Capital Management
AIGH Capital Management
Qube Research & Technologies
Palisade Capital Management
Renaissance Technologies

View all funds holding Castle Biosciences